Literature DB >> 19913612

Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.

Irina Kadiyala1, Yihua Loo, Krishnendu Roy, Janet Rice, Kam W Leong.   

Abstract

Oral vaccination is one of the most promising applicationpan>s of polymeric nanoparticles. Using two different in vitro cellular models to partially reproduce the characteristics of intestinal enterocytes and M-cells, this study demonstrates that nanoparticle transport through the M-cell co-culture model is 5-fold that of the intestinal epithelial monolayer, with at least 80% of the chitosan-DNA nanoparticles uptaken in the first 30 min. Among the properties of nanoparticles studied, ligand decoration has the most dramatic effect on the transcytosis rate: transferrin modification enhances transport through both models by 3- to 5-fold. The stability of the nanoparticles also affects transport kinetics. Factors which de-stabilize the nanoparticles, such as low charge (N/P) ratio and addition of serum, result in aggregation and in turn decreases transport efficiency. Of these stability factors, luminal pH is of great interest as an increase in pH from 5.5 to 6.4 and 7.4 leads to a 3- and 10-fold drop in nanoparticle transport, respectively. Since soluble chitosan can act as an enhancer to increase paracellular transport by up to 60%, this decrease is partially attributed to the soluble chitosan precipitating near neutral pH. The implication that chitosan-DNA nanoparticles are more stable in the upper regions of the small intestine suggests that higher uptake rates may occur in the duodenum compared to the ileum and the colon. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913612      PMCID: PMC2818464          DOI: 10.1016/j.ejps.2009.11.002

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  33 in total

1.  Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.

Authors:  I M van der Lubben; J C Verhoef; A C van Aelst; G Borchard; H E Junginger
Journal:  Biomaterials       Date:  2001-04       Impact factor: 12.479

2.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

Authors:  H Q Mao; K Roy; V L Troung-Le; K A Janes; K Y Lin; Y Wang; J T August; K W Leong
Journal:  J Control Release       Date:  2001-02-23       Impact factor: 9.776

3.  Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model.

Authors:  I M van der Lubben; F A C van Opdorp; M R Hengeveld; J J M Onderwater; H K Koerten; J C Verhoef; G Borchard; H E Junginger
Journal:  J Drug Target       Date:  2002-09       Impact factor: 5.121

4.  PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination.

Authors:  Marie Garinot; Virginie Fiévez; Vincent Pourcelle; François Stoffelbach; Anne des Rieux; Laurence Plapied; Ivan Theate; Hélène Freichels; Christine Jérôme; Jacqueline Marchand-Brynaert; Yves-Jacques Schneider; Véronique Préat
Journal:  J Control Release       Date:  2007-05-22       Impact factor: 9.776

5.  Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice.

Authors:  Joon Lin Chew; Claudia Betina Wolfowicz; Hai-Quan Mao; Kam W Leong; Kaw Yan Chua
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

6.  Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes.

Authors:  H Le Buanec; C Vetu; A Lachgar; M A Benoit; J Gillard; S Paturance; J Aucouturier; V Gane; D Zagury; B Bizzini
Journal:  Biomed Pharmacother       Date:  2001-07       Impact factor: 6.529

7.  Isolation and functional characteristics of adherent phagocytic cells from mouse Peyer's patches.

Authors:  T T MacDonald; P B Carter
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

8.  Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.

Authors:  Zeng B Zhu; Sharmila K Makhija; Baogen Lu; Minghui Wang; Angel A Rivera; Meredith Preuss; Fen Zhou; Gene P Siegal; Ronald D Alvarez; David T Curiel
Journal:  Virology       Date:  2004-07-20       Impact factor: 3.616

9.  Microparticle transport in the human intestinal M cell model.

Authors:  Yin Hwa Lai; Martin J D'Souza
Journal:  J Drug Target       Date:  2008-01       Impact factor: 5.121

Review 10.  Chitosan nanoparticles for oral drug and gene delivery.

Authors:  Katherine Bowman; Kam W Leong
Journal:  Int J Nanomedicine       Date:  2006
View more
  16 in total

Review 1.  Therapeutic applications of hydrogels in oral drug delivery.

Authors:  Lindsey A Sharpe; Adam M Daily; Sarena D Horava; Nicholas A Peppas
Journal:  Expert Opin Drug Deliv       Date:  2014-06       Impact factor: 6.648

Review 2.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 3.  Nanotechnology: an effective tool for enhancing bioavailability and bioactivity of phytomedicine.

Authors:  Thirumurugan Gunasekaran; Tedesse Haile; Tedele Nigusse; Magharla Dasaratha Dhanaraju
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

4.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery.

Authors:  Amrita Banerjee; Jianping Qi; Rohan Gogoi; Jessica Wong; Samir Mitragotri
Journal:  J Control Release       Date:  2016-07-30       Impact factor: 9.776

5.  Comparative study of nanoparticle-mediated transfection in different GI epithelium co-culture models.

Authors:  Yihua Loo; Christopher L Grigsby; Yvonne J Yamanaka; Malathi K Chellappan; Xuan Jiang; Hai-Quan Mao; Kam W Leong
Journal:  J Control Release       Date:  2012-02-03       Impact factor: 9.776

6.  Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.

Authors:  Lichen Yin; Ziyuan Song; Qiuhao Qu; Kyung Hoon Kim; Nan Zheng; Catherine Yao; Isthier Chaudhury; Haoyu Tang; Nathan P Gabrielson; Fatih M Uckun; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2013-04-22       Impact factor: 15.336

7.  PEGylated Chitosan for Nonviral Aerosol and Mucosal Delivery of the CRISPR/Cas9 System in Vitro.

Authors:  Hairui Zhang; Tania F Bahamondez-Canas; Yajie Zhang; Jasmim Leal; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2018-10-01       Impact factor: 4.939

8.  Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells.

Authors:  Blanka Halamoda Kenzaoui; Maya R Vilà; Josep M Miquel; Feride Cengelli; Lucienne Juillerat-Jeanneret
Journal:  Int J Nanomedicine       Date:  2012-03-05

Review 9.  Progress and future of in vitro models to study translocation of nanoparticles.

Authors:  Hedwig M Braakhuis; Samantha K Kloet; Sanja Kezic; Frieke Kuper; Margriet V D Z Park; Susann Bellmann; Meike van der Zande; Séverine Le Gac; Petra Krystek; Ruud J B Peters; Ivonne M C M Rietjens; Hans Bouwmeester
Journal:  Arch Toxicol       Date:  2015-05-15       Impact factor: 5.153

10.  Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.

Authors:  Meenakshi Malhotra; Catherine Tomaro-Duchesneau; Shyamali Saha; Imen Kahouli; Satya Prakash
Journal:  Int J Nanomedicine       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.